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The development and function of our brain are governed by a genetic blueprint, which reflects dynamic
changes over the history of evolution. Recent progress in genetics and genomics, facilitated by next-gener-
ation sequencing and single-cell sorting, has identified numerous genomic loci that are associated with
a neuroanatomical or neurobehavioral phenotype. Here, we review some of the genetic changes in both pro-
tein-coding and noncoding regions that affect brain development and evolution, as well as recent progress in
brain transcriptomics. Understanding these genetic changes may provide novel insights into neurological
and neuropsychiatric disorders, such as autism and schizophrenia.All life forms develop, reproduce, and age based on their genetic
blueprint. The humangenetic blueprint iswritten in approximately
three billion base pairs (bp) and contains protein-coding genes
(estimated at 21,000 or fewer), RNA genes (e.g., microRNAs, pro-
moter-associated short RNAs, small nucleolar RNAs, and long
noncoding RNAs, which are estimated at 18,400), cis-regulatory
elements (including promoters and transcription factor binding
sites), long-range regulatory elements (namely, enhancers, re-
pressors/silencers, and insulators), and transposable elements
(ENCODE Project Consortium, 2011, 2012; Lander, 2011; Lander
et al., 2001; Pennisi, 2012).
The human genome changes over both short and long
timescales. Genetic changes that occurred as Homo sapiens
diverged from the common ancestor of primates are identifiable
as human-specific regions of the genome (Pollard et al., 2006).
Subtler genetic changes, especially relating to susceptibility
to infectious diseases, have occurred during human migration
out of Africa and settlement in certain geographical and biolog-
ical environments (Sabeti et al., 2007; Tishkoff et al., 2007).
Furthermore, genetic changes continue to occur, and can cause
disease, when inherited within a family as dominant (e.g., Hun-
tington’s disease) or recessive (e.g., microcephaly) alleles (Gil-
more and Walsh, 2013; Ross and Tabrizi, 2011). Most recently,
we have been discovering the extent to which genetic changes
that occur somatically, during the development and lifetime of
an individual, can affect the brain (Jamuar et al., 2014; Poduri
et al., 2013).
One may wish that the development and evolution of the hu-
man brain could be explained simply by a discrete set of hu-
man-specific genetic changes within the context of conserved
brain development among mammals, including mice. However,
there are many qualitative and quantitative differences in the
development of the cerebral cortex (neocortex) between humans
and mice (Geschwind and Rakic, 2013; Hill and Walsh, 2005),
and even our understanding of the development of the mouse
brain is far from complete. Nonetheless, there has been recent
progress in our understanding of human brain development
and evolution due to new methods and tools available in ge-
netics, genomics, and developmental biology (Table 1). Here,
we will review the present state of research on the geneticchanges affecting the development and evolution of the human
neocortex.
Identification of Evolutionarily Important Genomic
Regions by Comparisons between Species
One way to identify genetic changes that may have contributed
to the evolution of the human brain is to compare the human
genome to genomes of other species, both closely and distantly
related, and determine which genetic changes may be relevant.
Currently, genome sequences are available for archaic humans,
such as the Neanderthal (Green et al., 2010) and the Denisovan
(Reich et al., 2010), and for apes, such as the chimpanzee (Chim-
panzee Sequencing and Analysis Consortium, 2005), the ma-
caque (Gibbs et al., 2007), the orangutan (Locke et al., 2011),
the gorilla (Scally et al., 2012), and the bonobo (Pru¨fer et al.,
2012), as well as dozens of non-primate species.
However, mere comparison of the genomes fromdifferent spe-
cies is not sufficient to identify functionally relevant genetic
changes, as there are countless differences between the human
genome and the genomes of other species. For example, there
are nearly 20 million genomic loci that differ between humans
and chimpanzees. One important caveat here is that some of
the apparent differences between humans and non-humans
may simply reflect technical effects such as low sequencing
coverage and improper annotation of primate genomes com-
pared to the human genome. The currently annotated human
genome is a compilation of thousands of individual genomes.
Thus, intra-species population variability is well documented in
humans (Abecasis et al., 2012). In contrast, some of the archaic
human and primate genomes are based on a single individual.
Second, in most cases, the functional consequences of species
differences in sequence are unknown. Any genetic change has
the potential to elicit a robust phenotypic change, but it is nearly
impossible to predict which genetic change is relevant. Then, out
of 20 million or more candidates, where should we start?
One plausible starting point is to focus on the sequences that
are uniquely present, absent, or variable in the human genome,
as those sequences might contribute to unique features of the
human brain. A search based on protein basic local alignment
search tool (BLASTP) revealed a few de novo genes that areDevelopmental Cell 32, February 23, 2015 ª2015 Elsevier Inc. 423
Table 1. Tools for Identification and Characterization of Genetic Changes Shaping the Human Brain
Tool Advantages Disadvantages
Whole-exome sequencing efficient sequencing of all the protein-coding
genes (180,000 exons) in the human genome
unable to identify structural and noncoding variants,
although there are some tools to detect copy number
variations from exome data
Whole-genome sequencing sequencing of the entire genome of an individual the function of the majority of the human genome is
incompletely understood; thus, much sequencing data
are often difficult to interpret; also, whole-genome
sequencing is costly, at least for now
Single-cell sequencing genome and transcriptome sequencing of
individual cells detects cell-to-cell variability
requires amplification of the limited DNA and RNA in a
single cell, which can introduce errors
RNA sequencing reveals how each protein-coding gene or RNA
gene is utilized in a given cellular context
detection of genes with low expression levels is difficult;
multiple cell types can confound the interpretation
Chromosome
conformation capture
reveals chromosomal interactions influencing
gene expression, such as interaction between
an enhancer and a promoter of a protein-coding
gene
can be costly due to depth of sequencing needed,
depending on method; requires a great number of cells;
multiple cell types can generate noise and confound the
interpretation, although single-cell chromosome
conformation capture was recently developed
Clustered regularly interspaced
short palindromic repeats
(CRISPR)
genome editing by breaking the target DNA, which
introduces frameshift mutations via non-homologous
end joining or facilitates homologous recombination
off-target effects; efficiency in the brain awaits further
optimization
Multiple types of genome and transcriptome sequencing tools are available for identification of genetic changes that may contribute to human brain
development, evolution, and disease. Functional characterization of the genetic changes is expedited by CRISPR, a genome-editing tool.
Developmental Cell
Reviewunique to the human genome (Knowles and McLysaght, 2009;
Wu et al., 2011). Interestingly, RNA sequencing (RNA-seq) data
indicate that these genes have their highest expression levels
in the neocortex and testes, although their functions have not
been systematically examined. Conversely, a systematic search
for human-specific deletions compared with other primate ge-
nomes identified 510 such deletions in humans that fall almost
exclusively in noncoding regions (McLean et al., 2011). One
such deletion removes a forebrain germinal zone enhancer
near the tumor suppressor gene growth arrest and DNA-dam-
age-inducible, gamma (GADD45G), suggesting a possible role
in the expansion of specific brain regions in humans. However,
a general consensus is that humans have a remarkably similar
number of protein-coding genes to model organisms such as
mice and worms and that most of the essential evolutionary
changes did not happen by simple gene addition or subtraction.
Another evolutionary approach has been to focus on genomic
loci that are well conserved throughout vertebrate evolution
but are strikingly different in humans; these regions have been
named ‘‘human accelerated regions (HARs)’’ (Bird et al., 2007;
Bush and Lahn, 2008; Pollard et al., 2006; Prabhakar et al.,
2008). So far, 2,700 HARs have been identified, again most
of them in noncoding regions: at least 250 of these HARs
seem to function as developmental enhancers in the brain (Capra
et al., 2013). One of them (HAR1) encodes a long noncoding RNA
(lncRNA) that is expressed specifically in Cajal-Retzius neurons
in the developing human neocortex. Cajal-Retzius neurons are
a heterogeneous population of cell types in the marginal zone
and layer 1 of the developing neocortex that produces reelin, a
large, secreted, extracellular matrix glycoprotein. Reelin controls
processes of neuronal migration and positioning in the devel-
oping neocortex, so the expression pattern of this HAR suggests
intriguing potential roles in regulating the shape or structure of
the cerebral cortex.424 Developmental Cell 32, February 23, 2015 ª2015 Elsevier Inc.The analysis of convergent evolution represents a third avenue
of comparative genomics that has been very powerful of late but
has not yet been explored in relation to the structure of the
neocortex per se. A particular phenotype can evolve inde-
pendently in species belonging to different lineages, creating
analogous structures that have similar form or function. An
evolutionarily convergent phenotype may be correlated with
similar genomic differences occurring independently in the two
lineages that evolved the same trait independently. Using this
approach, the genetic basis of vitamin C deficiency in certain pri-
mates including humans has recently been uncovered (Hiller
et al., 2012). Similarly, echolocation in bats and dolphins (Parker
et al., 2013), the electric organs (Gallant et al., 2014), the origin of
the nervous system (Moroz et al., 2014), and the domestication
of wild rabbits (Carneiro et al., 2014) have been studied. This
method may be very powerful in the future to apply to cerebral
cortical evolution as well.
Identification of Evolutionarily Important Genomic
Regions Using Human Genetics
The basic premise of human genetics is simple: where there is a
phenotype, there is likely to be an associated genetic (or epige-
netic) change. Identification of a genetic change in humans and
validation in cell and animal models can explain the mechanistic
cause of the phenotype. There are more than seven billion peo-
plemanifesting diverse phenotypes, which are skillfully identified
and characterized by physicians (Brenner, 2003). In conjunction
with traditional human genetics approaches, next-generation,
high-throughput, deep sequencing is a powerful tool to identify
genetic changes that are compatible with life and affect develop-
ment of the human brain.
It is relatively easy to detect and understand the functional
consequences of changes in protein-coding sequences, com-
pared to noncoding mutations. Mutations in a coding sequence
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gulatory element associated with the same coding sequence.
Nonsense mutations, as well as missense mutations, especially
in evolutionarily conserved amino acids (aa), can lead to gain or
loss of function of a protein. A coding sequence mutation can be
introduced intomodel organisms by overexpressing themutated
coding sequence or by knocking out, knocking down, or knock-
ing in the orthologous gene. The tissues, cell types, and subcel-
lular organelles in which a protein is expressed can suggest
potential roles of the protein. Knowledge of any interacting pro-
teins and of the aa sequence homology to other well-character-
ized proteins can also help identify the potential functions of a
protein.
In this regard, forkhead box protein p2 (FOXP2) provides a
prime example of protein-coding sequence mutations that iden-
tify genes with potential evolutionary importance. A mutation in
FOXP2 was first identified in a British family with a severe lan-
guage disorder (Lai et al., 2001). The affected individuals have
a severe impairment in the selection and sequencing of fine
oral and facial movements, the ability to break upwords into their
constituent phonemes, and the production and comprehension
of word inflections and syntax. Their non-verbal abilities are rela-
tively intact. FOXP2 encodes a forkhead-winged helix family
transcription factor that is highly expressed in the developing
and mature neocortex (Ferland et al., 2003), and the mutation
(R553H) disrupts the forkhead DNA-binding domain.
Comparison of the FOXP2 cDNAs from multiple species indi-
cates that the human FOXP2 protein differs at only three aa
residues from the mouse ortholog and at two residues from
the chimpanzee, gorilla, and rhesus macaque orthologs (Enard
et al., 2002). These aa changes are functionally critical as the hu-
man and chimpanzee FOXP2 have strikingly different transcrip-
tional targets, many of which are involved in CNS development
(Konopka et al., 2009). Human-specific FOXP2 targets also
include genes involved in branchial arch formation and craniofa-
cial development, which may be required for spoken language.
Mice carrying humanized FoxP2 show accelerated learning,
qualitatively different ultrasonic vocalizations, and increased
dendrite length and synaptic plasticity in the medium spiny neu-
rons of the striatum. These findings suggest that the cortico-
striatal circuitry mediates speech and language in humans
(Enard et al., 2009; Fujita et al., 2008; Schreiweis et al., 2014;
Shu et al., 2005). Although it is hard to know whether mouse ul-
trasonic vocalizations are analogous to human language, FoxP2
and cortico-striatal circuitry seem to control vocal learning in
songbirds, which communicate via vocalizations like humans
(Wohlgemuth et al., 2014). Perhaps surprisingly, Neanderthals,
Denisovans, and modern humans share an identical FOXP2 pro-
tein (Meyer et al., 2012; Noonan et al., 2006). Thus, at least some
neurobiological and physiological aspects of speech and lan-
guage probably emerged after divergence from chimpanzees.
FOXP2 is a part of a larger FOXP family that includes FOXP1,
FOXP3, and FOXP4. Their expression patterns are different, but
all FOXP transcription factors have a highly similar structure,
suggesting that they emerged by duplication. Conserved fork-
head domains are found in eukaryotic organisms from yeast to
humans, and the human genome contains more than forty FOX
genes that play diverse roles in development, metabolism, im-
munity, and cancer (Benayoun et al., 2011). Indeed, the majorityof human genes have been generated by gene duplication
(Ohno, 1970; Zhang, 2003). Duplicated genes diverge function-
ally over time by accumulating changes in the coding sequence
as well as in associated noncoding regulatory elements, which
alter protein expression patterns (Carroll et al., 2005; Conant
and Wolfe, 2008).
Analysis of the Slit-Robo Rho GTPase-activating protein 2
(SRGAP2) genes shows the potential role of gene duplication in
brain evolution (Charrier et al., 2012; Dennis et al., 2012).
SRGAP2 has been implicated in cerebral cortical development
in mice, especially in neuronal migration and morphogenesis,
and the F-BAR domain of SRGAP2 is required for its function
(Guerrier et al., 2009). Mice have only one form of the Srgap2
gene, but humans have four forms: one ancestral form
(SRGAP2A), which is orthologous to mouse Srgap2, and three
human-specific paralogs (SRGAP2B,SRGAP2C, andSRGAP2D)
that were produced by incomplete segmental duplication. Unlike
SRGAP2A,which consists of 1,071 aa, the 459-aa SRGAP2Band
SRGAP2C proteins have a truncated F-BAR domain. SRGAP2D
mRNA is subject to nonsense-mediated decay. The three hu-
man-specific paralogs are located in the human-lineage-specific
loci 1q21.1 and 1p12, both of which contain a number of genes
implicated in neurodevelopment (O’Bleness et al., 2012). The hu-
man-specific paralogs are also present in the Denisovan and
Neanderthal genomes, but not in the non-human primate ge-
nomes. Thus, the human-specific SRGAP2 paralogs emerged
when the genus Homo diverged from Australopithecus 2–3
million years ago (Dennis et al., 2012). SRGAP2B is expressed
as a pseudogene. With its truncated F-BAR domain, SRGAP2C
dimerizes with full-length SRGAP2A and inhibits SRGAP2A
function in a dominant-negative manner. Overexpression of
SRGAP2C in themouse brain results in sustained radial migration
of neurons as well as increased spine density and neoteny during
spine maturation, which are human-specific features of neuronal
development.
Genes controlling brain size or shape also exemplify evolution-
arily dynamic genomic regions identified by human genetics.
Primary microcephaly is an autosomal recessive neurodevelop-
mental disorder resulting in an abnormally small brain volume
of >2–3 SDs below themean, and some of the genes for this con-
dition have also been implicated as potentially active in human
brain evolution. Many of the known genetic mutations causing
human primary microcephaly target one subcellular organelle—
the centrosome (Gilmore and Walsh, 2013). Individuals with pri-
mary microcephaly show no obvious motor deficits but suffer
from intellectual disability and language delay. Microcephaly is
largely caused by mutations that disrupt genes encoding centro-
somal proteins: MCPH1, ASPM, CDK5RAP2, CENPJ, STIL,
WDR62, CEP152, and CEP63 (Bilgu¨var et al., 2010; Bond et al.,
2002; Bond et al., 2005; Guernsey et al., 2010; Jackson et al.,
2002; Kumar et al., 2009; Nicholas et al., 2010; Sir et al., 2011;
Yu et al., 2010). Intriguingly, a few microcephaly-associated
genes, notably ASPM and CDK5RAP2, show evidence for po-
sitive selection not only in primates but also across placental
mammals. The evolution of ASPM and CDK5RAP2 is strongly
correlatedwith brain size, suggesting their roles in brain evolution
(Montgomery and Mundy, 2014).
As microcephaly proteins are ubiquitously present in the
centrosome of most animal cells (Nigg and Raff, 2009), it isDevelopmental Cell 32, February 23, 2015 ª2015 Elsevier Inc. 425
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the rest of the body in most cases. The centrosome is the main
microtubule-nucleating organelle during mitosis (M phase). It is
composed of two centrioles: an old, fully maturemother centriole
and a young, immature daughter centriole. The mother centriole
forms the basal body of the primary cilium during G1 phase. After
centriole duplication at G1/S, the cell contains two centrosomes,
each consisting of a mother centriole and a daughter centriole.
However, one of the centrosomes contains the oldest (‘‘grand-
mother’’) centriole in the cell, which was the mother centriole in
the previous cell cycle. This inherent asymmetry between the
mother and daughter centrioles and, by extension, between
the two centrosomes in a dividing cell, seems to be critical to
the maintenance of stem cell character (Wang et al., 2009; Ya-
mashita et al., 2007). During cell division, the grandmother
centriole and the ciliary membrane linked to this centriole are
preferentially inherited by the daughter cell that is destined to
remain a neural stem or apical radial glial cell (Paridaen et al.,
2013; Taverna et al., 2014). Thus, in the absence of a micro-
cephaly protein, human neural progenitors may fail to asymmet-
rically inherit the ciliary membrane or grandmother centriole,
thereby losing stem cell character prematurely.
The centrosome-associated cell division machinery contains
at least three more proteins that carry modern human-specific
aa substitutions. Cancer susceptibility candidate 5 (CASC5), ki-
nesin family member 18A (KIF18A), and sperm-associated anti-
gen 5 (SPAG5) localize to the mitotic spindle, which is organized
by the centrosome, or to the kinetochore, which attaches chro-
mosomes to the spindle microtubules (Pa¨a¨bo, 2014; Pru¨fer
et al., 2014). The three proteins are expressed in the germinal
zones during mid-fetal brain development. These data suggest
that the centrosome-associated cell division machinery may be
critical to neocortical evolution.
Another crucial neurodevelopmental gene, AHI1, has under-
gone evolutionary changes along the human lineage (Ferland
et al., 2004). Mutations in AHI1 cause Joubert syndrome, a
congenital brainmalformation of the cerebellar vermis and brain-
stem. Individuals with Joubert syndrome have motor and behav-
ioral abnormalities, including an inability to walk due to severe
clumsiness and ‘‘mirror’’ movements, and cognitive and behav-
ioral disturbances. In particular, the human and non-human
primate aa sequences of the N-terminal coiled-coil domain of
AHI1 are highly divergent—and this domain is totally missing in
mice and rats—suggesting that AHI1 may play a crucial, hu-
man-specific role during neurodevelopment. Overall, the studies
of changes in protein-coding sequences have highlighted some
interesting leads.
Noncoding DNA and Human Brain Evolution
Even before the completion of the human genome project, it was
anticipated that protein-coding sequences alone could not fully
explain the human-specific aspects of our anatomy and physi-
ology. Human and chimpanzee proteins were already known to
be so similar that other regulatory mechanisms would presum-
ably be required to account for the biological differences be-
tween these species (King andWilson, 1975). Indeed, the human
genome project has made it clear that nearly 99% of the human
genome does not encode proteins and that the approximately
21,000 human protein-coding genes are in general surprisingly426 Developmental Cell 32, February 23, 2015 ª2015 Elsevier Inc.similar across placental mammals (Lander, 2011; Lander et al.,
2001; Venter et al., 2001).
Although the actual number of protein-coding genes in hu-
mans is much smaller than initial estimates of approximately
100,000 genes, alternative splicing has been recognized as an
important source of variation, potentially producing multiple
different functional mRNAs and proteins with diverse expression
patterns from the same gene (Keren et al., 2010; Nilsen and
Graveley, 2010). The synapse provides ample examples of alter-
native splicing events that diversify its components. Clustered
protocadherins are perhaps the most complex synapse-spe-
cificity and circuit-assembly molecules that are alternatively
spliced (Zipursky and Sanes, 2010). With numerous alternative
exons for multiple protein domains, there are approximately
350,000 possible, combinatorial protocadherin proteins from
about 60 Pcdh loci.
Neurexins, a highly polymorphic family of synaptic receptors,
exhibit distinct isoform-specific biochemical interactions and
synapse assembly functions. The KH-domain RNA-binding
protein SAM68 alternatively splices the Nrxn1 gene in an activ-
ity-dependent manner, thereby dynamically controlling Nrxn1
molecular diversity in the CNS (Iijima et al., 2011). In fact, a few
critical splicing factors in the nervous system have been re-
ported, such as NOVA, FMRP, RBFOX, and most recently,
nSR100/SRRM4 (Brown et al., 2001; Gehman et al., 2011; Irimia
et al., 2014; Jensen et al., 2000). nSR100 controls alternative
splicing of 3–15 nucleotide ‘‘microexons,’’ which in turn alters
protein-protein interactions, during neurogenesis. Reduced
levels of nSR100 and dysregulated neuronal microexons are
implicated in some cases of autism (Irimia et al., 2014). RBFOX
targets are also frequently dysregulated in autism, highlighting
the critical role of alternative splicing in brain development and
function (De Rubeis et al., 2014; Voineagu et al., 2011; Weyn-
Vanhentenryck et al., 2014).
In addition to alternative splicing, almost half of the known pro-
tein-coding genes in humans utilize alternative promoters. Each
promoter is regulated by a distinct set of transcription factors,
which drive diverse spatial and temporal expression patterns
(Davuluri et al., 2008). For example, the human brain-derived
neurotrophic factor (BDNF) gene has nine promoters that are
used in specific tissues and brain regions (Pruunsild et al.,
2007). Aberrant use of a promoter is associated with various dis-
eases. A polymorphism in the promoter region of the human
serotonin transporter gene SLC6A4 has also been associated
with several dimensions of neurosis and psychopathology (Hariri
et al., 2002).
G protein-coupled receptor 56 (GPR56) demonstrates how
noncoding elements and alternative promoters can control key
features of cerebral cortical development. GPR56 encodes a G
protein-coupled receptor that binds extracellular matrix ligands
and regulates normal neocortical development (Jeong et al.,
2013; Singer et al., 2013). Mutations in the coding sequences
cause polymicrogyria (‘‘too many small gyri’’) in most of the
neocortex (Piao et al., 2004). Recently, polymicrogyria restricted
to the neocortical areas surrounding the Sylvian fissure including
Broca’s area, the primary language area, was identified (Bae
et al., 2014). The causative mutation is found in theGPR56 locus
but disrupts a noncoding element, which constitutes a strong
neural promoter during development, in the 50-upstream
A B
Figure 1. Emergence and Evolution of a Gene
(A) GPR56 exemplifies how a novel gene arises and evolves. GPR56 is critical to neocortical development, especially gyral patterning. Its protein-coding
sequence arose when vertebrates and invertebrates diverged, probably by gene duplication of a preexisting adhesion G protein-coupled receptor (GPCR) with a
long N-terminal extracellular domain. When placental and non-placental mammals diverged, the number of noncoding elements was dramatically increased. The
majority of the novel noncoding elementswere derived from transposable elements. The placentalGpr56 gene obtained a critical noncoding element (red triangle)
that constitutes a robust neural promoter, which drives regional expression in the neocortex. GPR56 continued to obtain new noncoding elements, alternative
promoters, and untranslated exons in the primate lineage. Numerous transposon-derived noncoding elements are all over the humanGPR56 gene. Most of them
are likely to be evolutionarily recent, since the older insertions become mutated and unrecognizable. SINE, short interspersed nuclear elements; LINE, long
interspersed nuclear elements; LTR, long terminal repeat elements; DNA, DNA repeat elements; Simple, simple repeats or micro-satellites.
(B) Multiple alternative promoters of human GPR56 collectively drive gene expression in the entire neocortex (colored in blue). Loss of a specific noncoding
element, which corresponds to the red triangle in (A), and thus loss of the associated promoter, ablate GPR56 expression and cause neocortical malformation in
the areas surrounding the Sylvian fissure bilaterally (i.e., perisylvian polymicrogyria). The affected areas include Broca’s area, the primary language area for
speech. Presumably, the novel noncoding elements enabled more precise and complex neocortical patterning mediated by GPR56. Adapted from Bae et al.,
2014.
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has at least 17 alternative promoters, whereas mouseGpr56 has
only a handful (Figure 1). Intriguingly, the human noncoding
element directs gene expression in a highly restricted pattern,
whereas the mouse element directs more diffuse expression.
These data suggest that diversification of noncoding elements
and promoters results in region-specific gene expression in the
cortex, thus allowing independent development and functional
specialization of distinct neocortical regions.
Noncoding regions in the human genome have numerous
transposable elements, highly repetitive DNA, introns, and pseu-
dogenes, as well as RNA genes. What proportion of noncoding
DNA is functional is an open question, which deserves a sub-
stantial amount of careful study (Doolittle, 2013; ENCODE Proj-
ect Consortium, 2012; Palazzo and Gregory, 2014). Obviously,
not all DNA in the human genome can be functional. The human
genome (comprising three billion bp) contains roughly eight
times as much DNA as that of the pufferfish Fugu rubripes (0.4
billion bp) but is about one-fortieth the size of the genome of
the lungfish Protopterus aethiopicus (140 billion bp) (http://
www.genomesize.com) (Palazzo and Gregory, 2014). Therefore,
the relationship between genome size and the complexity of the
organism is not a straightforward one.
Transposable elements are the most prevalent type of non-
coding DNA, accounting for approximately 45% of the human
genome. Long interspersed nuclear element-1 (LINE1) retro-
transposons are autonomous transposable elements that can
retrotranspose a copy of their own RNA, as well as otherRNAs, such as short interspersed nuclear elements (SINEs),
and cellular mRNAs. Most transposable elements are inactive
due to mutations, but LINE1 is still active and has been impli-
cated in dozens of diseases (Hancks andKazazian, 2012). Trans-
posable elements clearly have been active over evolutionary
time to introduce innovations to the genome during evolution.
Many conserved noncoding elements were derived from trans-
posable elements. Comparison of placental and marsupial ge-
nomes demonstrates that the number of conserved noncoding
elements is sharply increased in the genome of placental mam-
mals (Lindblad-Toh et al., 2011; Mikkelsen et al., 2007). Over
the course of evolution, transposable elements provide novel
binding sites for the host transcriptional machinery and thus
help create novel regulatory networks (Davidson, 2010; Wray,
2007). For example, many of the complex alternative promoters
and exons of humanGPR56were derived from LINEs and SINEs
(Bae et al., 2014).
The concept that changes in noncoding sequence generated
evolutionary changes has been strongly supported by increas-
ingly systematic studies of regulatory elements that control
nervous system expression. Active regulatory elements are usu-
ally associated with p300/CBP and epigenetically marked
by H3K27ac. Thus, p300/CBP chromatin immunoprecipitation
sequencing followed by lacZ reporter mouse transgenesis can
systematically reveal enhancers active in the telencephalon
(http://enhancer.lbl.gov). This approach identified numerous po-
tential embryonic forebrain enhancers that are evolutionarily
conserved or divergent between mice and humans. At leastDevelopmental Cell 32, February 23, 2015 ª2015 Elsevier Inc. 427
Table 2. Resources for Neurogenetics
Name Contents Link
SFARI Gene a database of genes implicated in autism http://sfari.org/resources/sfari-gene
SchizophreniaGene a database of genes implicated in schizophrenia http://www.szgene.org
Allen Brain Atlas a comprehensive database of gene expression patterns and connectivity
maps in the brains of humans, non-human primates, and mice during
development and in adulthood
http://www.brain-map.org,
http://www.brainspan.org
Human Brain
Transcriptome
a database of spatio-temporal gene expression patterns in the developing
and adult human brain
http://hbatlas.org
VISTA Enhancer
Browser
a resource for experimentally validated human and mouse noncoding
fragments with gene enhancer activity as assessed in transgenic mice
http://enhancer.lbl.gov
ENCODE a comprehensive database of potentially functional elements in the human
genome: unannotated exons, regulatory elements, RNA genes, etc.
https://www.encodeproject.org
UCSC Genome
Browser
a user-friendly gateway to a large collection of genomes, gene expression,
regulation, variation, and evolution
http://genome.ucsc.edu
Ensembl a user-friendly gateway to a large collection of genomes, gene expression,
regulation, variation, and evolution
http://www.ensembl.org
CEEHRC Platform a database of epigenome http://www.epigenomes.ca
Multiple online resources provide information on genomes, epigenomes, brain transcriptomes, brain connectivity maps, and genes implicated in
autism and schizophrenia.
Developmental Cell
Reviewone-third of human brain candidate enhancers are unique to hu-
mans and not functionally conserved in mice, suggesting that a
significant portion of human brain enhancers emerged after the
divergence of primates and rodents (Visel et al., 2013) and that
changes in enhancer elements represent a dynamic evolutionary
mechanism.
Recently, the importance of noncoding RNAs in brain deve-
lopment, evolution, and disease has been gradually appreciated
(Esteller, 2011; Qureshi and Mehler, 2012; Sauvageau et al.,
2013). For example, there are more than 100 primate-specific
and 20 human-specific microRNAs that are expressed in the
developing brain (Berezikov, 2011). The primate-specific micro-
RNAs target cell-cycle and neurogenesis regulators, thereby
increasing proliferation of neocortical progenitors. Primate-spe-
cific co-evolution of microRNAs and their targets in the germinal
zones may have contributed to neocortical expansion in pri-
mates (Arcila et al., 2014).
Transcriptomic Analyses Reveal How the Human Brain
Develops and Evolves
Changes in the noncoding genome are reflected in differences in
levels or patterns of transcription, and our understanding of the
architecture of gene transcription has advanced considerably
in the last few years. RNA-seq of prenatal and postnatal brains
in health and disease has provided an enormous wealth of
data on gene expression (Table 2) (Hawrylycz et al., 2012; John-
son et al., 2009; Kang et al., 2011; Lein and Hawrylycz, 2014;
Miller et al., 2014; Pletikos et al., 2014; Zeng et al., 2012). The hu-
man brain expresses numerous genes; approximately 80%–
95% of protein-coding genes are expressed in at least one brain
region during at least one period of development or adulthood.
Co-expressed genes suggest anatomical structures, cell types,
and molecular pathways that are potentially critical to brain
development and function. Comparison of brain RNA-seq from
different species reveals evolutionarily conserved and divergent
gene expression patterns.428 Developmental Cell 32, February 23, 2015 ª2015 Elsevier Inc.The adult human neocortex has multiple distinct functional
areas, such as the visual area in the occipital lobe, the auditory
area in the temporal lobe, and Broca’s language area in the left
frontal lobe. Surprisingly, it turned out that transcription profiles
in the adult neocortex are relatively homogeneous throughout
the cortex, although a certain level of heterogeneity still does
exist (Hawrylycz et al., 2012; Kang et al., 2011; Pletikos et al.,
2014), suggesting that the distinct function of each neocortical
area becomes apparent only at a higher level of complexity
beyond gene expression. Comparison of the adult human and
non-human primate brain transcriptomes shows that primates
share common, closely matched gene expression patterns in
the neocortex, while the human frontal lobe is transcriptionally
more complex (Bernard et al., 2012; Konopka et al., 2012;
Pletikos et al., 2014). In contrast, the mouse neocortex trans-
criptome is markedly different from the primate transcriptome.
For example, the synaptic vesicle protein 2c (SV2C) gene is ex-
pressed preferentially in layer 3 pyramidal neurons in primates
but is expressed in layer 5 pyramidal neurons inmice. The prody-
norphin (PDYN) gene, which encodes dynorphin and other kappa
opioid receptor peptide agonists, is expressed in layers 4 and 5 in
primary visual cortex in primates but is expressed only in scat-
tered GABAergic interneurons in mice (Bernard et al., 2012).
The transcriptome of the developing, prenatal human neo-
cortex, however, is quite heterogeneous across different cortical
areas (Johnson et al., 2009; Kang et al., 2011; Miller et al., 2014).
First, transcriptional differences are found between different
neocortical areas (e.g., orbital/dorsolateral/ventrolateral/medial
prefrontal, motor-somatosensory, parietal association, temporal
auditory, temporal association, and occipital visual neocortex).
Each area expresses a large number of specific gene expression
and alternative splicing patterns, often with a rostrocaudal, me-
diolateral, or frontotemporal gradient. For example, cerebellin 2
precursor (CBLN2) is enriched in the prefrontal cortex, neuro-
peptide Y (NPY) in non-frontal areas, and FOXP2 in the perisyl-
vian cortex; the full-length isoform ROBO1a is enriched in the
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Reviewtemporal lobe, whereas the alternative short isoform ROBO1b is
slightly enriched in the prefrontal cortex. Regionally enriched
transcriptomes form a co-expression network; for example, the
developing prefrontal cortex has a distinct gene network that
contains a number of schizophrenia genes (Gulsuner et al.,
2013). Differentially expressed genes are more frequently asso-
ciated with human-specific evolution of putative cis-regulatory
elements (Johnson et al., 2009).
Transcriptional differences in the prenatal human are also pro-
nounced in different germinal and postmitotic layers. Laminar
transcriptomic signatures are likely to reflect the cellular diversity
and developmental processes of the prenatal human neocortex.
Excitatory neurons, which constitute the majority of neocortical
neurons, are derived from neocortical progenitors called radial
glial (RG) cells in a germinal zone called the ventricular zone
(VZ) (Ayoub et al., 2011; Fietz et al., 2012). RG cells and the VZ
are common to all mammals and express cell proliferation genes
(e.g., SOX2, PAX6, ASPM), with human RG cells showing a num-
ber of species-specific signaling pathways such as platelet
derive growth factor D (PDGFD) signaling (Lui et al., 2014). On
the other hand, differentiated, postmitotic neurons express
distinct neuronal genes (e.g., LMO4, FOXP1, CUX1). Remark-
ably, humans, non-human primates, and placental mammals
with an enlarged brain have an additional, expanded germinal
zone called the outer subventricular zone (OSVZ), where a
unique population of neocortical progenitors called outer or
basal RG cells are abundant (Betizeau et al., 2013; Fietz et al.,
2010; Hansen et al., 2010; Lui et al., 2011; Reillo et al., 2011;
Smart et al., 2002). However, theOSVZ showsminimal transcrip-
tional differences from the inner subventricular zone (Miller et al.,
2014), which awaits more sophisticated investigations, prefer-
ably based on single-cell transcriptomes, because individual dif-
ferences of neocortical progenitors may be obscured by pooled
population means.
In this regard, there are a couple of debates on progenitors
and the OSVZ in the neocortical development field. The first
debate is on how neocortical progenitors generate postmitotic
neurons diverse in shape, size, connectivity, and electrophysio-
logical and molecular properties. One theory is that a common
kind of progenitor sequentially generates all subtypes of neu-
rons, with progressive restriction of progenitor fate potential
(Guo et al., 2013). The other theory is that lineage-restricted or
distinct subtypes of progenitors co-exist and are pre-specified
to generate different subtypes of neurons (Franco et al., 2012).
As both theories were mainly explored in mice, other animals
with an enlarged and gyrencephalic neocortex should be exam-
ined rigorously and carefully to resolve this debate. The second
debate is on what roles outer RG cells in the OSVZ have played
for neocortical expansion in carnivores and primates during evo-
lution. Outer RG cells show unique morphology and cellular
movements and are abundant in primates and carnivores, while
they are virtually absent in mice. As neocortical expansion
strongly correlates with gyrification (Tallinen et al., 2014), poten-
tial roles of outer RG cells in gyrification and expansion were
explored. Examination of multiple mammals revealed that outer
RG cells are also present in the Amazonian agouti, a gyrence-
phalic rodent, and the marmoset, a lissencephalic primate (Gar-
cı´a-Moreno et al., 2012; Kelava et al., 2012). Thus, whereas the
mere presence of outer RG cells alone cannot explain gyrifica-tion, they are nonetheless in a key context to potentially regulate
gyral patterns. Perhaps specific ablation of outer RG cells in an-
imal models other than mice or examination of outer RG cells in
microcephalic brains during development may resolve this
debate.
Human-specific transcriptomic analyses and the above-
mentioned debates raise questions about the widespread use
of mice as proxies for humans in research on neocortical devel-
opment and function and in psychiatric drug development. The
features that are conserved between mice and humans are, no
doubt, of paramount importance, and thus will continue to be
studied. However, there are a few evolutionarily novel features
unique to the developing human or primate neocortex, such as
precursor neurons migrating into the cortical primordium from
the subpallium even before local neurogenesis in the VZ, von
Economo neurons located in layer 5 of the anterior cingulate
and frontoinsular cortex, and so on (Clowry et al., 2010; Gesch-
wind and Rakic, 2013; Radonjic et al., 2014). Hence, the precise
introduction of mutations that cause severe human neocortical
phenotypes into the mouse genome often leads to negligible
phenotypes in the mouse. Alternatively, larger animal models,
such as the ferret, a gyrencephalic carnivore, and the marmoset
(Fietz et al., 2010; Garcı´a-Moreno et al., 2012; Kelava et al.,
2012), or 3D culture of human neural stem cell-derived cerebral
organoids or mini-brains (Bae and Walsh, 2013; Lancaster
et al., 2013; Stein et al., 2014) may provide new insights into hu-
man neocortical development and evolution. Regardless,
caution must be taken against quick extrapolation of results
from ferrets, inbred mice, or cell culture systems to human
neocortical development per se. Both human fetal brain tissues
and animal/cell models need to be studied in parallel.
The Dynamic Genome of the Single Neuron
Somatic mutations, which arise during the cell divisions that
generate the embryo, have recently been implicated in several
important neurological diseases. Somatic mutations that were
identified in human hemimegalencephaly (HMG) revealed the
dysregulated phosphoinositide 3-kinase (PI3K)-AKT3-mTOR
pathway as the causative mechanism (Lee et al., 2012; Poduri
et al., 2012; Rivie`re et al., 2012). HMG patients suffer from intrac-
table epilepsy, which can be controlled only by surgical resection
of the affected brain tissue. Prior to the discovery of somatic mu-
tations in the PI3K-AKT3-mTOR pathway in HMG, the genetic
etiology of HMG was poorly understood, although there had
been rare cases of HMG associated with the overgrowth syn-
dromes tuberous sclerosis complex (TSC) (Cartwright et al.,
2005) and Proteus syndrome (Griffiths et al., 1994). Direct study
of resected tissue led to the identification of a recurrent AKT3
mutation (E17K) in HMG. AKT3 is a RAC-gamma serine/threo-
nine protein kinase that is highly expressed in the developing
neocortex, and the E17K mutation renders AKT3 constitutively
active (Lee et al., 2012; Poduri et al., 2012). Additional somatic
mutations causing HMG have been identified that implicate
key upstream and downstream components of this pathway,
namely PI3K and mTOR (Lee et al., 2012; Rivie`re et al., 2012).
These results are consistent with previous reports that HMG
is occasionally seen in patients with TSC. TSC is caused by
mutations in TSC1 and TSC2, which encode members of the
mTOR pathway. Surprisingly, levels of mosaicism as low asDevelopmental Cell 32, February 23, 2015 ª2015 Elsevier Inc. 429
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of the neocortex in HMG (Evrony et al., 2012; Lee et al., 2012; Po-
duri et al., 2012; Rivie`re et al., 2012).
Given the difficulty of detecting somatic mosaic mutations by
standard methods such as Sanger sequencing or even whole-
exome sequencing, it is not known how common a cause of
complex neurogenetic disease they are. A recent study of brain
malformations used ‘‘deep sequencing’’ of candidate genes to
an average read depth of more than 200 to identify mutations
that might be present in a small proportion of cells. Analysis of
leukocyte-derived DNA samples from 158 persons with brain
malformations identified somatic mosaicism that had been diffi-
cult to detect previously. This study revealed that such somatic
mutations represented more than a quarter of all identified muta-
tions and were often missed both by Sanger sequencing and by
some whole-exome sequencing with typical calling algorithms.
Substantial disability in the form of epilepsy and intellectual
disability could be caused by mutations present in as few as
10% of brain cells. Presumably, these mutations occurred in
the early post-zygotic stages before neurogenesis. This report
suggests that high-coverage sequencing panels provide an
important complement towhole-exome and genome sequencing
in the evaluation of somaticmutations in the human brain (Jamuar
et al., 2014).
While low levels of somatic mosaicism are clinically important,
they are also difficult to detect. Typical whole-genome se-
quencing or Sanger sequencing of pooled DNA from many cells
covers each base in the genome 50–60 times; at this level of
coverage, it is possible to dismiss low levels of true somatic
mosaicism as errors (false-negative results). One way to solve
this problem is to amplify and sequence the genomes of individ-
ual cells. Single-cell sequencing has already been used to eval-
uate the clonal evolution of tumors (Hou et al., 2012; Navin
et al., 2011; Xu et al., 2012) and the spontaneous mutation of
spermcells (Lu et al., 2012;Wang et al., 2012). In the humanbrain,
single-cell sequencing has been successfully used to detect so-
matic mosaicism in HMG and to evaluate the rate of somatic
LINE1 retrotransposition (Evrony et al., 2012). Single-cell
sequencing has also been used to measure the prevalence of
large copy number variants in the brain (McConnell et al., 2013;
Cai et al., 2014). Less than one unique insertion was detected
per neuron, suggesting that LINE1 retrotransposition is not a ma-
jor generator of neuronal diversity in the brain. Interestingly, sin-
gle-cell sequencing can repurpose the LINE1 retrotransposition
events for cell lineage analysis in the developing human brain
(Evrony et al., 2015).
One caveat of single-cell sequencing is that somaticmutations
that occurred during or after neurogenesis can be identified only
in surgically resected or postmortem brain tissues. Noninvasive
identification of somatic mosaicism limited to the brain is impos-
sible. Nonetheless, the optimization of single-cell and high depth
sequencing will allow us to address the role of somatic mosai-
cism in brain disorders, in cases where mosaic mutations are
detectable in a small proportion of accessible cells, such as leu-
kocytes and skin fibroblasts (Poduri et al., 2013).
Neurogenetics is Just the Beginning
Though the human brain is extremely complex, the proportion of
genes that govern its development, and for which we have tenta-430 Developmental Cell 32, February 23, 2015 ª2015 Elsevier Inc.tively assigned functions, grows inexorably. Functional studies
of human neurogenetic mutations are obviously challenging,
due to the fact that the human brain has evolved dramatically
in the last 2–3 million years, gaining novel circuits, cell types,
and signaling pathways that are rare or absent in animal models
(Geschwind and Rakic, 2013; Molna´r et al., 2014; Pa¨a¨bo, 2014).
Nonetheless, by identifying critical neural genes and studying
their functions in diverse model organisms using innovative
tools, Homo sapiens keeps marching on in the endeavor to un-
derstand its brain. Perhaps the process rather than the product
of this endeavor may help define who we are.
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